{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:11Z","timestamp":1786997891765,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.vaccine.2009.09.069","type":"journal-article","created":{"date-parts":[[2009,9,28]],"date-time":"2009-09-28T04:09:25Z","timestamp":1254110965000},"page":"7021-7026","source":"Crossref","is-referenced-by-count":108,"title":["Characteristics of antibody responses in tick-borne encephalitis vaccination breakthroughs"],"prefix":"10.1016","volume":"27","author":[{"given":"Karin","family":"Stiasny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidemarie","family":"Holzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz X.","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.09.069_bib1","series-title":"Immunization against diseases of public health importance","author":"WHO","year":"2005"},{"key":"10.1016\/j.vaccine.2009.09.069_bib2","series-title":"Vaccines","first-page":"1","article-title":"A short history of vaccination","author":"Plotkin","year":"2008"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.069_bib3","first-page":"CD001269","article-title":"Vaccines for preventing influenza in healthy adults","author":"Jefferson","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2009.09.069_bib4","series-title":"Vaccines","first-page":"177","article-title":"Hepatitis A vaccines","author":"Fiore","year":"2008"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.069_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jmv.20524","article-title":"Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines","volume":"78","author":"Zuckerman","year":"2006","journal-title":"J Med Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.069_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2893.2003.00400.x","article-title":"Hepatitis B vaccine\u2014do we need boosters?","volume":"10","author":"Banatvala","year":"2003","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.vaccine.2009.09.069_bib7","series-title":"Vaccines","first-page":"353","article-title":"Measles vaccine","author":"Strebel","year":"2008"},{"key":"10.1016\/j.vaccine.2009.09.069_bib8","series-title":"Vaccines","first-page":"311","article-title":"Japanese encephalitis vaccines","author":"Halstead","year":"2008"},{"key":"10.1016\/j.vaccine.2009.09.069_bib9","series-title":"Vaccines","first-page":"959","article-title":"Yellow fever vaccine","author":"Monath","year":"2008"},{"issue":"43","key":"10.1016\/j.vaccine.2009.09.069_bib10","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1016\/j.vaccine.2007.08.024","article-title":"Field effectiveness of vaccination against tick-borne encephalitis","volume":"25","author":"Heinz","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.069_bib11","series-title":"Virus Taxonomy. VIIIth Report of the International Committee on Taxonomy of Viruses","first-page":"981","article-title":"Family Flaviviridae","author":"Thiel","year":"2005"},{"issue":"Pt 1","key":"10.1016\/j.vaccine.2009.09.069_bib12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1099\/0022-1317-80-1-179","article-title":"Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia","volume":"80","author":"Ecker","year":"1999","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2009.09.069_bib13","series-title":"Fields virology","first-page":"1153","article-title":"Flaviviruses","author":"Gubler","year":"2006"},{"issue":"9627","key":"10.1016\/j.vaccine.2009.09.069_bib14","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(08)60800-4","article-title":"Tick-borne encephalitis","volume":"371","author":"Lindquist","year":"2008","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.vaccine.2009.09.069_bib15","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.17.18848-en","article-title":"A survey on cases of tick-borne encephalitis in European countries","volume":"13","author":"Donoso Mantke","year":"2008","journal-title":"Euro Surveill"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2009.09.069_bib16","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0264-410X(02)00811-3","article-title":"Tick-borne encephalitis\u2014pathogenesis, clinical course and long-term follow-up","volume":"21","author":"Haglund","year":"2003","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2009.09.069_bib17","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/S0264-410X(02)00819-8","article-title":"Diagnosis of tick-borne encephalitis","volume":"21","author":"Holzmann","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.069_bib18","series-title":"Vaccines","first-page":"841","article-title":"Tick-borne encephalitis virus vaccines","author":"Barrett","year":"2008"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.069_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0928-0197(97)00273-0","article-title":"Intrathecal IgM, IgA and IgG antibody response in tick-borne encephalitis. Long-term follow-up related to clinical course and outcome","volume":"8","author":"Gunther","year":"1997","journal-title":"Clin Diagn Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.069_bib20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s150100050051","article-title":"Laboratory findings in tick-borne encephalitis\u2014correlation with clinical outcome","volume":"28","author":"Kaiser","year":"2000","journal-title":"Infection"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2009.09.069_bib21","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0264-410X(02)00813-7","article-title":"TBE vaccination and the Austrian experience","volume":"21","author":"Kunz","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.069_bib22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00415-004-0329-z","article-title":"Two severe cases of tick-borne encephalitis despite complete active vaccination\u2014the significance of neutralizing antibodies","volume":"251","author":"Bender","year":"2004","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.069_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s15010-006-6614-2","article-title":"Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination","volume":"35","author":"Kleiter","year":"2007","journal-title":"Infection"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2009.09.069_bib24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijmm.2008.03.006","article-title":"Tick-borne encephalitis after active immunization","volume":"298","author":"Lotric-Furlan","year":"2008","journal-title":"Int J Med Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.069_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0042-6822(88)90161-4","article-title":"Sequence of the structural proteins of tick-borne encephalitis virus (western subtype) and comparative analysis with other flaviviruses","volume":"166","author":"Mandl","year":"1988","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.069_bib26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0042-6822(89)90246-8","article-title":"Genome sequence of tick-borne encephalitis virus (Western subtype) and comparative analysis of nonstructural proteins with other flaviviruses","volume":"173","author":"Mandl","year":"1989","journal-title":"Virology"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2009.09.069_bib27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1099\/0022-1317-57-2-263","article-title":"Homogeneity of the structural glycoprotein from European isolates of tick-borne encephalitis virus: comparison with other flaviviruses","volume":"57","author":"Heinz","year":"1981","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.069_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1128\/JCM.14.2.141-146.1981","article-title":"Comparison of two different enzyme immunoassays for detection of immunoglobulin M antibodies against tick-borne encephalitis virus in serum and cerebrospinal fluid","volume":"14","author":"Heinz","year":"1981","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.069_bib29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/BF01641297","article-title":"Detectability of IgM antibodies against TBE virus after natural infection and after vaccination","volume":"11","author":"Hofmann","year":"1983","journal-title":"Infection"},{"issue":"19","key":"10.1016\/j.vaccine.2009.09.069_bib30","doi-asserted-by":"crossref","first-page":"9557","DOI":"10.1128\/JVI.00080-06","article-title":"Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites","volume":"80","author":"Stiasny","year":"2006","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.069_bib31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/(SICI)1096-9071(199601)48:1<102::AID-JMV16>3.0.CO;2-I","article-title":"Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis","volume":"48","author":"Holzmann","year":"1996","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2009.09.069_bib32","series-title":"Vaccines","first-page":"1541","article-title":"Immunization in developing countries","author":"Hadler","year":"2008"},{"key":"10.1016\/j.vaccine.2009.09.069_bib33","series-title":"Fields virology","first-page":"487","article-title":"Immunization against viral diseases","author":"Graham","year":"2006"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.069_bib34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nri2494","article-title":"Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines","volume":"9","author":"Pollard","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.09.069_bib35","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1086\/509619","article-title":"Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom","volume":"194","author":"Auckland","year":"2006","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.069_bib36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1128\/CDLI.11.1.119-122.2004","article-title":"Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 Sao Paulo epidemic","volume":"11","author":"Pannuti","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"issue":"24","key":"10.1016\/j.vaccine.2009.09.069_bib37","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1016\/j.vaccine.2007.04.013","article-title":"Mumps outbreak in a highly vaccinated school population: assessment of secondary vaccine failure using IgG avidity measurements","volume":"25","author":"Park","year":"2007","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.vaccine.2009.09.069_bib38","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1001\/jama.263.18.2467","article-title":"Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population","volume":"263","author":"Edmonson","year":"1990","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.vaccine.2009.09.069_bib39","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1128\/JCM.30.7.1778-1782.1992","article-title":"Secondary immune response in a vaccinated population during a large measles epidemic","volume":"30","author":"Ozanne","year":"1992","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2009.09.069_bib40","series-title":"11th Conference of the International Society of Travel Medicine (CISTM11)","article-title":"How to re-establish seroprotection in travellers with a history of incomplete and\/or irregular TBE vaccination","author":"Schosser","year":"2009"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.069_bib41","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/(SICI)1096-9071(199703)51:3<242::AID-JMV17>3.0.CO;2-M","article-title":"Avidity determination of IgG directed against tick-borne encephalitis virus improves detection of current infections","volume":"51","author":"Gassmann","year":"1997","journal-title":"J Med Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.069_bib42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jcv.2004.07.014","article-title":"The importance of tick-borne encephalitis virus RNA detection for early differential diagnosis of tick-borne encephalitis","volume":"33","author":"Saksida","year":"2005","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2009.09.069_bib43","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.0105-2896.2006.00402.x","article-title":"Protective \u2018immunity\u2019 by pre-existent neutralizing antibody titers and preactivated T cells but not by so-called \u2018immunological memory\u2019","volume":"211","author":"Zinkernagel","year":"2006","journal-title":"Immunol Rev"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.069_bib44","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1128\/JVI.71.4.2921-2927.1997","article-title":"Pre- and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse model","volume":"71","author":"Kreil","year":"1997","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2009.09.069_bib45","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1086\/508293","article-title":"Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters","volume":"194","author":"Morrey","year":"2006","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09014030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09014030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T05:36:01Z","timestamp":1633930561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09014030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":45,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0264410X09014030"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.09.069","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}